Pregnancy should not delay cancer treatment, study suggests
the ONA take:
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy due to concerns over harm to the fetus, a new study published online ahead of print in The New England Journal of Medicine has shown.
For the international, case-control study, researchers compared children age 12 to 42 months who mothers received a cancer diagnosis during pregnancy with matched children of women without cancer.
Of the 129 children identified, 96 were exposed to chemotherapy, 11 to radiotherapy, 13 to surgery alone, and 2 to other drug treatment. Fourteen were not exposed to treatment.
Results showed that prenatal exposure to maternal cancer with or without treatment did not negatively affect cardiac, cognitive, or general development of children in early childhood.
"Our results show that fear of cancer treatment is no reason to terminate a pregnancy, that maternal treatment should not be delayed and that chemotherapy can be given. The study also shows that children suffer more from prematurity than from chemotherapy, so avoiding prematurity is more important than avoiding chemotherapy," said lead author Frédéric Amant, MD, PhD, a gynecological oncologist at the University Hospitals Leuven in Belgium and at Antoni van Leeuwenhoek in The Netherlands.
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|